Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-000624

Chief Scientific Officer gave up 41,851 shares (to pay taxes)

  • Chief Scientific Officer acquired 91,130 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2024-12-31 Option exercise +73,750 245,533 D: show line 1 in the form
Monahan Joseph Chief Scientific Officer 2024-12-31 Shares withheld for taxes −32,937 212,596 D: show line 2 in the form
Monahan Joseph Chief Scientific Officer 2025-01-02 Option exercise +17,380 229,976 D: show line 3 in the form
Monahan Joseph Chief Scientific Officer 2025-01-02 Shares withheld for taxes −8,914 221,062 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Monahan Joseph Chief Scientific Officer 2024-12-31 Option exercise · Restricted Stock Units −73,750 73,750 D: show line 5 in the form
Monahan Joseph Chief Scientific Officer 2025-01-02 Grant or award · Restricted Stock Units +52,667 52,667 D: show line 6 in the form
Monahan Joseph Chief Scientific Officer 2025-01-02 Option exercise · Restricted Stock Units −17,380 35,287 D: show line 7 in the form
Loading xslF345X05/form4-01032025_060109.xml…